PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

This clinical trial of pembrolizumab in combination with metronomic cyclophosphamide assesses the efficacy and safety of PD-1 targeting in combination with metronomic chemotherapy in sarcomas.

http://ift.tt/2sl5Lj1